Tennessee faces omicron surge with ‘extremely scarce’ supply of antibodies, other COVID-19 treatments
Tennessee health officials are scrambling to increase depleted stock of monoclonal antibody treatments amid a nationwide shortage as all but one version of the drugs they've relied on to keep COVID-19 patients out of hospitals are proving ineffective against the omicron variant.









